Significantly, the ROS scavenger NAC, the JNK inhibitor and anti-ceramide sphingolipid S1P all mitigated, but did not reverse, SC66-induced cytotoxicity in RCC cells. The gene discussed is MAPK8; the disease is renal cell carcinoma.